Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DATOPOTAMAB DERUXTECAN-DLNK vs DEFERIPRONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DATOPOTAMAB DERUXTECAN-DLNK vs DEFERIPRONE: Safety Overview

Metric DATOPOTAMAB DERUXTECAN-DLNK DEFERIPRONE
Total FAERS Reports 165 2,487
Deaths Reported 36 287
Death Rate 21.8% 11.5%
Hospitalizations 33 923
Average Patient Age 61.4 yrs 41.7 yrs
% Female Patients 89.2% 57.4%
FDA Approval Date N/A Apr 20, 2018
Manufacturer N/A Chiesi USA, Inc.
Route N/A ORAL
Marketing Status Prescription Prescription